Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Overview of beginner-friendly HYSA options, focusing on accessibility, straightforward terms, and competitive rates.
24,631 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Bitcoin sits roughly 43% below its all-time high as macro headwinds and fund outflows weigh on sentiment. This report...
Jim Cramer says the on-the-ground reality for NVIDIA looks sturdier than feared, a view that could lift NVIDIA stock ...
A private luncheon for the largest holders of a Trump-themed memecoin is back at Mar-a-Lago, renewing headlines about...
Ukraine expands its drone-defense footprint in the Middle East, signaling a broader role for Kyiv as global markets w...
A Global Partners LP COO sold nearly $740k worth of units in a short window. This article explains what insider trade...
JPMorgan has begun a pilot that compares junior bankers' self-reported hours to computer activity, including keystrok...
Henry Hub natural gas vaulted to $7.72 in January before tumbling to $3.62 in February, forcing traders to pick sides...
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
Broadcom reported a strong Q1 FY2026 with AI-driven growth and a deep backlog, setting up a targeted, three-year broa...
Binance unveils a regional communications push, introduces new perpetual contracts, and plans to drop select trading ...
Hedge-fund CIOs say the refining space offers persistent profit potential due to structural capacity limits, even as ...